High-Dose Melphalan and the Development of Hematopoietic Stem-Cell Transplantation: 25 Years Later-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

High-Dose Melphalan and the Development of Hematopoietic Stem-Cell Transplantation: 25 Years Later

Published:2008-05-10 Issue:14 Volume:26 Page:2240-2243
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Lazarus Hillard M.¹,Phillips Gordon L.²,Herzig Roger H.³,Hurd David D.⁴,Wolff Steven N.⁵,Herzig Geoffrey P.³

Affiliation:

1. Department of Medicine, University Hospitals Case Medical Center, Ireland Cancer Center, Case Western Reserve University

2. Department of Medicine, University of Rochester Medical Center, Rochester, NY

3. Department of Blood and Marrow Transplant, University of Louisville, James Graham Brown Cancer Center, Louisville, KY

4. Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC

5. Department of Internal Medicine, Meharry Medical College, Nashville, TN

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

http://ascopubs.org/doi/pdfdirect/10.1200/JCO.2007.14.7827

Reference43 articles.

1. Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer.

2. Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

3. Hematopoietic rescue after high-dose chemotherapy using autologous peripheral-blood progenitor cells or bone marrow: a randomized comparison.

4. EBMT activity survey 2004 and changes in disease indication over the past 15 years

5. Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?;Blood Reviews;2024-05

2. Oral Therapies for Multiple Myeloma;Oncology & Haematology;2022

3. Test‐dose pharmacokinetics guided melphalan dose adjustment in reduced intensity conditioning allogeneic transplant for non‐malignant disorders;British Journal of Clinical Pharmacology;2021-06-13

4. Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies;Annals of Hematology;2021-01-03

5. Amifostine reduces gastro-intestinal toxicity after autologous transplantation for multiple myeloma;Leukemia & Lymphoma;2018-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3